Nrf2-mediated antioxidant and detoxifying enzyme induction by a combination of curcumin and sulforaphane

doi:10.5246/jcps.2016.08.062

中国药学(英文版) ›› 2016, Vol. 25 ›› Issue (8): 559-569.DOI: 10.5246/jcps.2016.08.062

• 【传统中药和植物药的癌症预防专栏】 • 下一篇

Nrf2-mediated antioxidant and detoxifying enzyme induction by a combination of curcumin and sulforaphane

Francisco Fuentes^1#, Yury Gomez^2#, Ximena Paredes-Gonzalez², Avantika Barve³, Sujit Nair⁴, Siwang Yu⁵, Constance Lay Lay Saw², Ah-Ng Tony Kong^2*

1. Facultad de Agronomía e Ingeniería Forestal, Pontificia Universidad Católica de Chile, Casilla 306-22, Santiago, Chile
2. Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Jersey 08854, USA
3. Novartis Institutes for Biomedical Research, East Hanover, NJ-07470, USA
4. Amrita Cancer Discovery Biology Laboratory, Amrita Vishwa Vidyapeetham University, Amritapuri, Clappana P.O., Kollam, Kerala-690525, India
5. School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China

收稿日期:2016-03-15 修回日期:2016-04-10 出版日期:2016-09-01 发布日期:2016-04-24
通讯作者: Tel.: +848-455-6369, Fax: +732-455-3134, E-mail: KongT@pharmacy.rutgers.edu
基金资助:
Part by Institutional Funds and by R01-CA118947, R01-CA152826, from the National Cancer Institute (NCI), R01-AT007065 from the National Center for Complementary and Alternative Medicines (NCCAM) and the Office of Dietary Supplements (ODS).

Nrf2-mediated antioxidant and detoxifying enzyme induction by a combination of curcumin and sulforaphane

Francisco Fuentes^1#, Yury Gomez^2#, Ximena Paredes-Gonzalez², Avantika Barve³, Sujit Nair⁴, Siwang Yu⁵, Constance Lay Lay Saw², Ah-Ng Tony Kong^2*

1. Facultad de Agronomía e Ingeniería Forestal, Pontificia Universidad Católica de Chile, Casilla 306-22, Santiago, Chile
2. Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, New Jersey 08854, USA
3. Novartis Institutes for Biomedical Research, East Hanover, NJ-07470, USA
4. Amrita Cancer Discovery Biology Laboratory, Amrita Vishwa Vidyapeetham University, Amritapuri, Clappana P.O., Kollam, Kerala-690525, India
5. School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, China

Received:2016-03-15 Revised:2016-04-10 Online:2016-09-01 Published:2016-04-24
Contact: Tel.: +848-455-6369, Fax: +732-455-3134, E-mail: KongT@pharmacy.rutgers.edu
Supported by:
Part by Institutional Funds and by R01-CA118947, R01-CA152826, from the National Cancer Institute (NCI), R01-AT007065 from the National Center for Complementary and Alternative Medicines (NCCAM) and the Office of Dietary Supplements (ODS).

摘要/Abstract

摘要：

The dietary phytochemicals curcumin (CUR) and sulforaphane (SFN) have shown remarkable cancer chemopreventive effects in many model systems. This study was designed to investigate the induction of Nrf2-mediated antioxidant enzymes by combining doses of CUR and SFN and the effect of their combination on the Nrf2-ARE (antioxidant response element) response in HepG2-C8 cells. We hypothesized that the combination of the polyphenol CUR and the isothiocyanate SFN could enhance the induction of AREs and Nrf2-target enzymes. HepG2-C8 cells were treated with a combination of low doses of CUR, SFN or both. The induction of Nrf2-mediated antioxidant and phase II detoxifying enzymes–heme oxygenase-1 (HO-1) and UDP-glucuronosyltransferase-1A (UGT1A)–was measured by real-time RT-PCR and western blotting. ARE-luciferase activity was also quantified. Low doses of CUR (10 µM) and SFN (12.5 µM) significantly induced the expression of HO-1 and UGT1A1 proteins. Through the use of chemical inhibitors of mRNA and protein synthesis, the combination of CUR and SFN was shown to affect the transcriptional regulation of both HO-1 and UGT1A1. Additionally, the combination of CUR and SFN synergisticallyinduced the expression of Nrf2- and ARE-luciferase activity in HepG2-C8 cells. Thus, CUR and SFN at low concentrations augment therapeutic effects in HepG2-C8 cells. The enhanced ARE-luciferase activity of combined CUR and SFN treatment could partly explain the significant induction of the Nrf2-target enzymes HO-1 and UGT1A1. Taken together, our results suggest that combining low doses of CUR and SNF could be a promising strategy for cancer chemoprevention in humans.

关键词: Antioxidant response element, Curcumin, HepG2-C8 cells, HO-1, Nrf2, Sulforaphane, UGT1A1

Abstract:

Key words: Antioxidant response element, Curcumin, HepG2-C8 cells, HO-1, Nrf2, Sulforaphane, UGT1A1

中图分类号:

R962

Supporting:

Francisco Fuentes, Yury Gomez, Ximena Paredes-Gonzalez, Avantika Barve, Sujit Nair, Siwang Yu, Constance Lay Lay Saw, Ah-Ng Tony Kong. Nrf2-mediated antioxidant and detoxifying enzyme induction by a combination of curcumin and sulforaphane[J]. 中国药学(英文版), 2016, 25(8): 559-569.

参考文献

[1] Chan, R.; Lok, K.; Woo, J. Mol. Nutr. Food Res. 2008, 53, 201-216.
[2] Lam, T.K.; Gallicchio, L.; Lindsley, K.; Shiels, M.; Hammond, E.; Tao, X.G.; Chen, L.; Robinson, K.A.; Caulfield, L.E.; Herman, J.G.; Guallar, E.; Alberg, A.J. Cancer Epidemiol. Biomarkers Prev. 2009, 18, 184-195.
[3] Tang, L.; Zirpoli, G.R.; Guru, K.; Moysich, K.B.; Zhang, Y.; Ambrosone, C.B.; McCann, S.E. Cancer Epidemiol. Biomarkers Prev. 2008, 17, 938-944.
[4] Arikawa, A.Y.; Gallaher, D.D. J. Nutr. 2008, 138, 526-532.
[5] Chan, C.; Lin, H.J.; Lin, J. Int. J. Oncol. 2008, 33, 415-419.
[6] Lee, J.S.; Surh, Y.S. Cancer Lett. 2005, 224, 171-184.
[7] Talalay, P. Biofactors. 2000, 12, 5-11.
[8] Boddupalli, S.; Mein, J.R.; Lakkanna, S.; James, D.R. Fron.Genetics. 2012, 3, 7.
[9] Navarro, S.L.; Li, F.; Lampe, J.W. Food Function. 2011, 2, 579-587.
[10] Zhu, M.; Fahl, W.E. Biochem. Biophys. Res. Commun. 2001, 289, 212-219.
[11] Lee, J.H.; Khor, T.O.; Shu, L.; Su, Z.Y.; Fuentes, F.; Kong, A.N.T. Pharmacol. Ther. 2013, 137, 153-171.
[12] Jeong, W.S.; Keum, Y.S.; Chen, C.; Jain, M.R.; Shen, G.; Kim, J.H.; Li, W.; Kong, A.N. J. Biochem. Mol. Biol. 2005, 38, 167-176 .
[13] Prawan, A.; Keum, Y.S.; Khor, T.O.; Yu, S.; Nair, S.; Li, W.; Hu, L.; Kong, A.N. Pharm. Res. 2008, 25, 836-844.
[14] Saw, C.L.; Yang, A.Y.; Huang, M.T.; Liu, Y.; Lee, J.H.; Khor, T.O.; Su, Z.Y.; Shu, L.; Lu, Y.; Conney, A.H.; Kong, A.N. Cell Bioscience. 2014, 4, 39.
[15] Keum, Y.S.; Yu, S.; Chang, P.P.; Yuan, X.; Kim, J.H.; Xu, C.; Han, J.; Agarwal, A.; Kong, A.N. Cancer Res. 2006, 66, 8804-8813.
[16] Khor, T.O.; Fuentes, F.; Shu, L.; Paredes-Gonzalez, X.; Yang, A.Y.; Liu, Y.; Smiraglia, D.J.; Yegnasubramanian, S.; Nelson, W.G.; Kong, A.N. Cancer Pre. Res. 2014, 7, 1186-1197.
[17] Hayes, J.D.; McMahon, M. Trends Biochem. Sci. 2009, 34, 176-188.
[18] Itoh, K.; Chiba, T.; Takahashi, S.; Ishii, T.; Igarashi, K.; Katoh, Y. Biochem. Biophys. Res. Commun. 1997, 236, 313-322.
[19] Hatcher, H.; Planalp, R.; Cho, J.; Torti, F. Cell Mol. life Sci. 2008, 65, 1631-1652.
[20] Boyanapalli, S.S.; Kong, A.N.T. Curr. Pharm. Rep. 2015, 1-11.
[21] Surh, Y.J.; Chun, K.S. Adv. Exp. Med. Biol. 2007, 595, 149-172.
[22] Khor, T.O.; Huang, Y.; Wu, T.Y.; Shu, L.; Lee, J.; Kong, A.N.T. Biochem. Pharmacol. 2011, 82, 1073-1078.
[23] Cao, J.; Liu, Y.; Jia, L.; Zhou, H.M.; Kong, Y.; Yang, G.; Jiang, L.P.; Li, Q.J.; Zhong, L.F. Free Radic. Biol. Med. 2007, 43, 968-975.
[24] Wang, H.; Khor, T.O.; Shu, L.; Su, Z.; Fuentes, F.; Lee, J.H.; Kong, A.N. Anti-cancer Agents Med. Chem. 2012, 257-269.
[25] Fuentes, F.; Paredes-Gonzalez, X.; Kong, A.N. Curr. Pharm. Rep. 2015, 1-18.
[26] Leoni, O.; Iori, R.; Palmieri, S. Biotechnol Bioeng. 2000, 68, 660-664.
[27] Dinkova-Kostova, A.T.; Kostov, R.V. Trends Mol. Med. 2012, 18, 337-347.
[28] Hong, F.; Freeman, M.L.; Liebler, D.C. Chem. Res. Toxicol. 2005, 18, 1917-1926.
[29] Jiang, Z.Q.; Chen, C.; Yang, B.; Hebbar, V.; Kong, A.N. Life Sci. 2003, 72, 2243-2253.
[30] Wang, H.; Khor, T.O.; Yang, Q.; Huang, Y.; Wu, T.Y.; Saw, C.L.; Lin, W.; Androulakis, I.P.; Kong, A.N. Mol. Pharm. 2012, 9, 2819-2827.
[31] Gills, J.J.; Jeffery, E.H.; Matusheski, N.V.; Moon, R.C.; Lantvit, D.D.; Pezzuto, J.M. Cancer Lett. 2006, 236, 72-79.
[32] Khor, T.O.; Hu, R.; Shen, G.; Jeong, W.S.; Hebbar, V.; Chen, C.; Xu, C.; Nair, S.; Reddy, B.; Chada, K.; Kong, A.N. Biopharm. Drug Dispos. 2006, 27, 407-420.
[33] Reddy, B.S. Subcell Biochem. 2007, 42, 213-225.
[34] Sarkar, F.H.; Li, Y.W. Acta Pharmacol. Sin. 2007, 28, 1305-1315.
[35] Su, Z.Y.; Shu, L.; Khor, T.O.; Lee, J.H.; Fuentes, F.; Kong, A.N. Top. Curr. Chem. 2013, 329, 133-162.
[36] Yu, R.; Mandlekar, S.; Lei, W.; Fahl, W.E.; Tan, T.H.; Kong, A.N. J. Biol. Chem. 2000, 275, 2322-2327.
[37] Fuentes, F.; Shu, L.; Lee, J.H.; Su, Z.Y.; Lee, K.R.; Kong, A.N.T.; Bode, A.M.; Dong, Z. Eds. Springer New York: 2014, 53-83.
[38] McNally, S.J.; Harrison, E.M.; Ross, J.A.; Garden, O.J.; Wigmore, S.J. Int. J. Mol. Med. 2007, 19, 165-172.
[39] Cheung, K.L.; Khor, T.O.; Kong, A.N. Pharm. Res. 2009, 26, 224-231.
[40] Chou, T.C. Pharmacol. Rev. 2006, 58, 621-681.
[41] Zhang, C.; Su, Z.Y.; Khor, T.O.; Shu, L.; Kong, A.N.T. Biochem. Pharmacol. 2013, 85, 1398-1404.
[42] Zhang, Y.; Talalay, P.; Cho, C.G.; Posner, G.H. Proc. Natl. Acad. Sci. USA. 1992, 89, 2399-2403.
[43] Boyanapalli, S.S.; Paredes-Gonzalez, X.; Fuentes, F.; Zhang, C.; Guo, Y.; Pung, D.; Saw, C.L.; Kong, A.N. Chem. Res. Toxicol. 2014, 27, 2036-2043.
[44] Kong, A.N.; Yu, R.; Hebbar, V.; Chen, C.; Owuor, E.; Hu, R.; Ee, R.; Mandlekar, S. Mutat. Res. 2001, 480, 231-241.
[45] Kwak, M.K.; Egner, P.A.; Dolan, P.M.; Ramos-Gomez, M.; Groopman, J.D.; Itoh, K.; Yamamoto, M.; Kensler, T.W. Mutat. Res. 2001, 480, 305-315.
[46] Kim, J.H.; Xu, C.; Keum, Y.S.; Reddy, B.; Conney, A.; Kong, A.N. Carcinogenesis. 2006, 27, 475-482.
[47] Nair, S.; Hebbar, V.; Shen, G.; Gopalakrishnan, A.; Khor, T.O.; Yu, S.; Xu, C.; Kong, A.N. Pharm. Res. 2008, 25, 387-399.
[48] Barve, A.; Khor, T.O.; Hao, X.; Keum, Y.S.; Yang, C.S.; Reddy, B.; Kong, A.N. Pharm. Res. 2008, 25, 2181-2189.

Nrf2-mediated antioxidant and detoxifying enzyme induction by a combination of curcumin and sulforaphane

Nrf2-mediated antioxidant and detoxifying enzyme induction by a combination of curcumin and sulforaphane

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	吴悔, 宁港, 李波男, 周兴. Nrf2对睾丸微环境的影响及其在男性疾病中的研究进展[J]. 中国药学(英文版), 2023, 32(7): 513-526.
[2]	王昭景, 许青霞, 许京, 徐嵬, 杨秀伟. 补骨脂宁通过激活Nrf2/HO-1并抑制NF-κB信号通路在过氧化氢诱导的HT22细胞和脂多糖诱导的BV2细胞上发挥抗氧化和抗神经炎症作用[J]. 中国药学(英文版), 2023, 32(2): 85-100.
[3]	张帆, 王晓慧, Abdulaziz Ahmed A. Saad, 席莉莉, 马小花, 石阿茜, 魏玉辉. 基于肝药酶CYP3A4、SULT2A1和UGT1A1探究京尼平的代谢解毒路径[J]. 中国药学(英文版), 2022, 31(8): 608-621.
[4]	胡金, 薛佳俊, 申娟. 本维莫德治疗特应性皮炎及银屑病作用机制的研究进展[J]. 中国药学(英文版), 2022, 31(12): 901-911.
[5]	李荣, 宋利华, 刘杰, 白杨, 杜玉茗, 林春华, 苏秀媛, 于宗学. 利格列汀对糖尿病Wistar大鼠心脏保护作用的研究[J]. 中国药学(英文版), 2021, 30(4): 334-346.
[6]	Tengku Siti Hajar Haryuna, Agustinus Hamonangan Winston Purba, Farhat Farhat, Soehartono Taat Putra. The effect of curcumin as an antioxidant on cochlea fibroblasts in ototoxic rat models[J]. 中国药学(英文版), 2018, 27(12): 847-854.
[7]	Sri Agus Sudjarwo, Koerniasari Eraiko, Giftania Wardani Sudjarwo, Koerniasari. Antioxidant activity of curcumine as protector on methylmercury induced-pancreas damage in mice[J]. 中国药学(英文版), 2017, 26(3): 196-201.
[8]	何柳, 徐江丽, 郭丽梅, 阙琳玲, 尹文琤, 曹宝山, 余四旺. Nrf2/ARE信号通路保护奥沙利铂所致小鼠肝毒性[J]. 中国药学(英文版), 2017, 26(10): 709-718.
[9]	Asia Abed Al-Mahmood, Limin Shu, Hyuck Kim, Christina Ramirez, Douglas Pung, Yue Guo, Wenji Li, Ah-Ng Tony Kong. Prostate cancer and chemoprevention by natural dietary phytochemicals[J]. 中国药学(英文版), 2016, 25(9): 633-650.
[10]	Tengku Siti Hajar Haryuna, Ramsi Lutan, Faathir Agung Ainul Taufika, Ratna Anggraeni, Tengku Siti Harilza Zubaidah. Effect of Curcuma longa L. extract on the AP1 expression in rat cochlear fibroblasts under noise conditions[J]. 中国药学(英文版), 2016, 25(9): 690-694.
[11]	杨倩, 陈刚, 杨洋, 蔡雪婷, 庞中化, 胡春萍, 张双全, 曹鹏. 刺芒柄花素通过诱导Nrf2表达缓解DSS诱导的小鼠溃疡性结肠炎[J]. 中国药学(英文版), 2016, 25(3): 178-188.
[12]	Sujit Nair, Ah-Ng Tony Kong. Pharmacometrics of nutraceutical sulforaphane and its implications in prostate cancer prevention[J]. 中国药学(英文版), 2016, 25(1): 12-22.
[13]	杨思敏, 姬利延, 阙琳玲, 王夔, 余四旺. 二甲双胍激活Nrf2信号并诱导抗氧化基因的表达[J]. 中国药学(英文版), 2014, 23(12): 837-843.
[14]	阙琳玲, 王欣竹, 钱鹏展, 曹宝山, 王夔, 余四旺*. 叔丁基对苯二酚上调Nrf2调控的基因表达并减轻环磷酰胺导致的小鼠血液毒性[J]. 中国药学(英文版), 2014, 23(1): 39-45.
[15]	阙琳玲, 王荟霞, 曹宝山, 杨晓达, 王夔, 余四旺^*. 转录因子Nrf2在癌症化学预防与化疗耐药性中的调控和功能[J]. , 2011, 20(1): 5-19.